Medicare Enrolled
Dr. Dhiren Dave, M.D.
Urology Physician · Somerville, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dave from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dave?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dave
Dr. Dhiren Dave is an urology physician in Somerville, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dave performed 8,388 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dave received a total of $5,046 from 60 pharmaceutical and/or device companies across 288 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dave is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 13% volume in NJ
$5,046 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,388
Medicare services
Top 13% in NJ for urology physician
Not available
Unique patients (not deduplicated)
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,760 | $19 | $139 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
617 | $3 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
444 | $99 | $830 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
371 | $68 | $591 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
274 | $39 | $329 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 267 | $130 | $1,100 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
225 | $11 | $298 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
68 | $144 | $1,142 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
55 | $11 | $94 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
52 | $202 | $1,641 |
| Simple change of bladder tube | 47 | $81 | $659 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
47 | $50 | $398 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $63 | $462 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $73 | $731 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $127 | $1,097 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
23 | $26 | $232 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $111 | $854 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
15 | $110 | $1,640 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,046
Total received (2018-2024)
Avg $721/year across 7 years
Top 24% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
288
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$945
2023
$1,113
2022
$865
2021
$374
2020
$282
2019
$835
2018
$631
Payments by company (2024)
Astellas Pharma US Inc
$218
PFIZER INC.
$111
UROGEN PHARMA, INC.
$73
ABBVIE INC.
$57
180 Medical, Inc.
$54
Sumitomo Pharma America, Inc.
$51
COLOPLAST CORP
$49
Bayer Healthcare Pharmaceuticals Inc.
$41
Dendreon Pharmaceuticals LLC
$31
Ferring Pharmaceuticals Inc.
$31
Cycle Pharmaceuticals Inc
$29
PROCEPT BioRobotics Corporation
$25
Calyxo, Inc.
$22
Teleflex LLC
$22
Avation Medical, Inc.
$21
IMMUNITYBIO, INC.
$17
Gilead Sciences, Inc.
$17
Telix Pharmaceuticals
$16
Janssen Biotech, Inc.
$16
Blue Earth Diagnostics Limited
$15
Tolmar, Inc.
$14
Axonics, Inc.
$13
Top 3 companies account for 42.6% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,029
Janssen Biotech, Inc.
$501
PFIZER INC.
$304
Bayer Healthcare Pharmaceuticals Inc.
$217
Bayer HealthCare Pharmaceuticals Inc.
$213
Amgen Inc.
$212
Dendreon Pharmaceuticals LLC
$171
Sumitomo Pharma America, Inc.
$161
TOLMAR Pharmaceuticals, Inc.
$130
Gilead Sciences, Inc.
$128
Teleflex LLC
$114
ABBVIE INC.
$113
Coloplast Corp
$111
180 Medical, Inc.
$109
Boston Scientific Corporation
$76
UROGEN PHARMA, INC.
$73
AbbVie, Inc.
$73
Merck Sharp & Dohme LLC
$71
COLOPLAST CORP
$64
UroGen Pharma, Inc.
$63
Hollister Incorporated
$59
Avadel Specialty Pharmaceuticals, LLC
$58
MEDIVATION FIELD SOLUTIONS LLC
$58
AbbVie Inc.
$57
Axonics, Inc.
$54
Medtronic, Inc.
$53
Antares Pharma, Inc.
$44
Myovant Sciences Inc.
$43
DAVOL INC.
$38
Palette Life Sciences, Inc.
$34
Agiliti Surgical, Inc.
$34
AstraZeneca Pharmaceuticals LP
$33
MILLICENT US INC
$33
Ferring Pharmaceuticals Inc.
$31
Merck Sharp & Dohme Corporation
$30
Cycle Pharmaceuticals Inc
$29
Mission Pharmacal Company
$28
Blue Earth Diagnostics Limited
$26
PROCEPT BioRobotics Corporation
$25
Olympus America Inc.
$23
Calyxo, Inc.
$22
Cook Medical LLC
$22
Avation Medical, Inc.
$21
Myriad Genetic Laboratories, Inc.
$20
Verity Pharmaceuticals Inc.
$20
Endo Pharmaceuticals Inc.
$18
Accord Healthcare, Inc.
$18
IMMUNITYBIO, INC.
$17
Foundation Medicine, Inc.
$17
Telix Pharmaceuticals
$16
GENZYME CORPORATION
$16
Acerus Pharmaceuticals Corporation
$15
Janssen Scientific Affairs, LLC
$15
Pacira Pharmaceuticals Incorporated
$14
Tolmar, Inc.
$14
DENTSPLY IH AB
$13
UROVANT SCIENCES INC
$13
Aytu BioScience, Inc
$12
Janssen Pharmaceuticals, Inc
$12
Retrophin, Inc.
$10
Top 3 companies account for 36.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS 800 Artificial Urinary Sphincter · ANKTIVA · AQUABEAM SYSTEM · ARISTA AH · Axonics · Axumin · BOTOX · CAMCEVI · CONTINENCE CARE · CVAC ASPIRATION SYSTEM · Cook Medical Celect Platinum · ELIGARD · ERLEADA · EXPAREL · Erleada · FOUNDATIONONE CDX · GEMTESA · GREENLIGHT · ILLUCCIX · INTERSTIM · INTRAROSA · Intrarosa · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ONLI · ORGOVYX · POSLUMA · PROVENGE · Prolaris · Prolia · Sonablate · SpeediCath · TOVIAZ · Tiopronin · Titan · Trelstar · Trodelvy · URIBEL · UROLIFT · Uribel · VaPro Plus Pocket · VaPro Pocket · Vivally · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
132
County median income
$135,960
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL - SOMERSET
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dave is a mixed practice specialist, with above-average Medicare volume (top 13% in NJ), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dave experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Dave performed 5,760 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dave receive payments from pharmaceutical companies?
Yes. Dr. Dave received a total of $5,046 from 60 companies across 288 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dave's costs compare to other urology physicians in Somerville?
Dr. Dave's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dave) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Somerville
Browse urology physicians in Somerville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology